Ralph Graeser

AstraZeneca (United Kingdom) — United Kingdom

Medicine · Health Sciences

30h-index2.7kcitations158works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(27), 3D Printing in Biomedical Research(26), Cancer Research and Treatments(23), Nanoparticle-Based Drug Delivery(20), HER2/EGFR in Cancer Research(19)

Publications158 total

The Second Mitochondria‐Derived Activator of Caspases Mimetic <scp>BI</scp> 891065 in Patients With Advanced Solid Tumors: Results From Two Phase I Studies
Cancer Medicine·2025Open Access
Comprehensive biomarker and modeling approach to support dose finding for BI 836880, a VEGF/Ang-2 inhibitor
Journal of Translational Medicine·2024· 2 citedOpen Access
Supplementary Table 1, Figures 1-3 from EphB4 Promotes Site-Specific Metastatic Tumor Cell Dissemination by Interacting with Endothelial Cell–Expressed EphrinB2
2023Open Access
Data from EphB4 Promotes Site-Specific Metastatic Tumor Cell Dissemination by Interacting with Endothelial Cell–Expressed EphrinB2
2023Open Access
Data from EphB4 Promotes Site-Specific Metastatic Tumor Cell Dissemination by Interacting with Endothelial Cell–Expressed EphrinB2
2023Open Access
Supplementary Table 1, Figures 1-3 from EphB4 Promotes Site-Specific Metastatic Tumor Cell Dissemination by Interacting with Endothelial Cell–Expressed EphrinB2
2023Open Access
Supplementary Figure 3 from Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion &lt;i&gt;In vitro&lt;/i&gt; and Inhibits Metastasis-Like Lung Invasion &lt;i&gt;In vivo&lt;/i&gt;
2023Open Access
Supplementary Figure 5 from Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion &lt;i&gt;In vitro&lt;/i&gt; and Inhibits Metastasis-Like Lung Invasion &lt;i&gt;In vivo&lt;/i&gt;
2023Open Access
Supplementary Figure 1A from Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion &lt;i&gt;In vitro&lt;/i&gt; and Inhibits Metastasis-Like Lung Invasion &lt;i&gt;In vivo&lt;/i&gt;
2023Open Access
Supplementary Figure 2 from Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion &lt;i&gt;In vitro&lt;/i&gt; and Inhibits Metastasis-Like Lung Invasion &lt;i&gt;In vivo&lt;/i&gt;
2023Open Access
Supplementary Figure 1C from Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion &lt;i&gt;In vitro&lt;/i&gt; and Inhibits Metastasis-Like Lung Invasion &lt;i&gt;In vivo&lt;/i&gt;
2023Open Access
Supplementary Figure 1B from Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion &lt;i&gt;In vitro&lt;/i&gt; and Inhibits Metastasis-Like Lung Invasion &lt;i&gt;In vivo&lt;/i&gt;
2023Open Access
Supplementary Figure 4 from Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion &lt;i&gt;In vitro&lt;/i&gt; and Inhibits Metastasis-Like Lung Invasion &lt;i&gt;In vivo&lt;/i&gt;
2023Open Access
Supplementary Figure 1A from Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion &lt;i&gt;In vitro&lt;/i&gt; and Inhibits Metastasis-Like Lung Invasion &lt;i&gt;In vivo&lt;/i&gt;
2023Open Access
Supplementary Figure Legends from Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion &lt;i&gt;In vitro&lt;/i&gt; and Inhibits Metastasis-Like Lung Invasion &lt;i&gt;In vivo&lt;/i&gt;
2023Open Access
Supplementary Figure Legends from Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion &lt;i&gt;In vitro&lt;/i&gt; and Inhibits Metastasis-Like Lung Invasion &lt;i&gt;In vivo&lt;/i&gt;
2023Open Access
Supplementary Figure 1B from Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion &lt;i&gt;In vitro&lt;/i&gt; and Inhibits Metastasis-Like Lung Invasion &lt;i&gt;In vivo&lt;/i&gt;
2023Open Access
Data from Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion &lt;i&gt;In vitro&lt;/i&gt; and Inhibits Metastasis-Like Lung Invasion &lt;i&gt;In vivo&lt;/i&gt;
2023Open Access
Supplementary Figure 5 from Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion &lt;i&gt;In vitro&lt;/i&gt; and Inhibits Metastasis-Like Lung Invasion &lt;i&gt;In vivo&lt;/i&gt;
2023Open Access
Supplementary Figure 1C from Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion &lt;i&gt;In vitro&lt;/i&gt; and Inhibits Metastasis-Like Lung Invasion &lt;i&gt;In vivo&lt;/i&gt;
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Felix Kratz(13), N. Esser(11), Clemens Unger(9), Suzana Vidic(6), Barbara Kappes(6), Ronald De Hoogt(5), Yolanda Chong(5), Peter Jantscheff(5), Ulrich Massing(5), Catarina Brito(4), Kjersti Gjerde(4), Michaël Barbier(4), Wytske M. van Weerden(4), Iduna Fichtner(4), Rainer Haag(4), André Warnecke(4), Richard M. Franklin(4), Vittorio Ziroli(4), Christoph Schäechtele(4), Khalid Abu Ajaj(4)